KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $93.8 million.

  • Fulgent Genetics' Total Liabilities fell 511.71% to $93.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.8 million, marking a year-over-year decrease of 511.71%. This contributed to the annual value of $90.8 million for FY2024, which is 1101.21% down from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Total Liabilities is $93.8 million, which was down 511.71% from $88.2 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Total Liabilities ranged from a high of $197.5 million in Q1 2021 and a low of $83.0 million during Q1 2025
  • In the last 5 years, Fulgent Genetics' Total Liabilities had a median value of $103.4 million in 2024 and averaged $115.9 million.
  • As far as peak fluctuations go, Fulgent Genetics' Total Liabilities surged by 238355.34% in 2021, and later tumbled by 3954.04% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Total Liabilities stood at $112.8 million in 2021, then increased by 2.96% to $116.2 million in 2022, then fell by 12.17% to $102.0 million in 2023, then decreased by 11.01% to $90.8 million in 2024, then grew by 3.3% to $93.8 million in 2025.
  • Its Total Liabilities was $93.8 million in Q3 2025, compared to $88.2 million in Q2 2025 and $83.0 million in Q1 2025.